Bartlett & Co Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Bartlett & Co Wealth Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-62	Closed	-$1.19K	–	1329
2025 Q1	$1.19K	Hold	62	–	–	﹤0.01%	1108
2024 Q4	$2.23K	Hold	62	–	–	﹤0.01%	1032
2024 Q3	$2.63K	Buy	+62	New	+$2.63K	﹤0.01%	1023
2021 Q3	–	Sell	-3	Closed	-$292	–	1070
2021 Q2	$292	Hold	3	–	–	﹤0.01%	1052
2021 Q1	$265	Hold	3	–	–	﹤0.01%	1085
2020 Q4	$287	Buy	+3	New	+$309	﹤0.01%	1184

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bartlett & Co Wealth Management's TNDM Position: Q2 2025 in Review

Bartlett & Co Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 62 shares — an estimated $1.19K sold.

Bartlett & Co Wealth Management first reported a position in TNDM in Q4 2020 and held it in 6 quarters. The position peaked at $2.63K in Q3 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

Bartlett & Co Wealth Management reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
Bartlett & Co Wealth Management sold 62 Tandem Diabetes Care shares in Q2 2025, an estimated $1.19K.
Bartlett & Co Wealth Management first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 6 quarters.
Bartlett & Co Wealth Management's Tandem Diabetes Care position peaked at $2.63K in Q3 2024.
270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.